Design and Discovery of Functionally Selective Serotonin 2C (5-HT2c) Receptor Agonists

被引:30
|
作者
Cheng, Jianjun [1 ,5 ]
McCorvy, John D. [2 ]
Giguere, Patrick M. [2 ,6 ]
Zhu, Hu [2 ,7 ]
Kenakin, Terry [3 ,4 ]
Roth, Bryan L. [2 ]
Kozikowski, Alan P. [1 ]
机构
[1] Univ Illinois, Dept Med Chem & Pharmacognosy, Coll Pharm, Drug Discovery Program, Chicago, IL 60612 USA
[2] Univ N Carolina, Sch Med, Natl Inst Mental Hlth, Psychoact Drug Screening Program, Chapel Hill, NC 27599 USA
[3] Univ N Carolina, Sch Med, Div Pharmacol, Chapel Hill, NC 27599 USA
[4] Univ N Carolina, Sch Med, Div Chem Biol & Med Chem, Chapel Hill, NC 27599 USA
[5] ShanghaiTech Univ, iHuman Inst, 99 Haike Rd, Shanghai 201210, Peoples R China
[6] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada
[7] NCATS, Div Preclin Innovat, 9800 Med Ctr Dr, Rockville, MD 20850 USA
关键词
MELATONIN RECEPTORS; TRANSDUCTION; IDENTIFICATION; LIGANDS; POTENT; DRUG;
D O I
10.1021/acs.jmedchem.6b01194
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
On the basis of the structural similarity of our previous 5-HT2c agonists with the melatonin receptor agonist tasimelteon and the putative biological cross-talk between serotonergic and melatonergic systems, a series of new (2,3-dihydro)benzofuran-based compounds were designed and synthesized. The compounds were evaluated for their selectivity toward 5-HT2A, 5-HT2B, and 5HT(2c) receptors in the calcium flux assay with the ultimate goal to generate selective 5-HT2c agonists. Selected compounds were studied for their functional selectivity by comparing their transduction efficiency at the G protein signaling pathway versus beta-arrestin recruitment. The most functionally selective compound (+)-7e produced weak beta-arrestin recruitment and also demonstrated less receptor desensitization compared to serotonin in both calcium flux and phosphoinositide (PI) hydrolysis assays. We report for the first time that selective 5-HT2c agonists possessing weak beta-arrestin recruitment can produce distinct receptor desensitization properties.
引用
收藏
页码:9866 / 9880
页数:15
相关论文
共 50 条
  • [1] Discovery of N-substituted 2-phenylcyclopropylmethylamines as functionally selective serotonin 2C (5-HT2C) receptor agonists for potential use as antipsychotic medications
    Zhang, Guiping
    Cheng, Jianjun
    McCorvy, John
    Lorello, Paul
    Caldarone, Barbara
    Roth, Bryan
    Kozikowski, Alan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [2] Discovery of novel potent and selective agonists of the serotonin (5-HT) 5-HT2C receptor as neurotherapeutics
    Mack, Helmut
    Backfisch, Gisela
    Blaich, Guenter
    Braje, Wilfried
    Erhard, Thomas
    Haupt, Andreas
    Kling, Andreas
    Lakics, Viktor
    Lynch, James
    Mugnaini, Manolo
    Pohlki, Frauke
    Relo, Ana
    Schaefer, Kai
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [3] Discovery and development of selective 5-HT2C receptor agonists for obesity
    Dourish, C. T.
    Adams, D. R.
    Bentley, J.
    Benwell, K.
    Bickerdike, M. J.
    Harrison, K.
    Kennett, G. A.
    Knight, A. R.
    Lightowler, S. L.
    Malcolm, C.
    Misra, A.
    Vickers, S. P.
    Cliffe, I. A.
    Coassolo, P.
    Frei, B.
    Mizrahi, J.
    Stalder, H.
    Stephan-Guldner, M.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2004, 18 : 127 - 127
  • [4] Altered expression of the 5-HT2C (serotonin 2C) receptor in schizophrenia
    Crossland, N
    Eastwood, SL
    East, SZ
    Harrison, PJ
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2000, 12 : 240 - 240
  • [5] Serotonin 5-HT2C receptor agonists:: For the treatment of obesity
    Miller, KJ
    MOLECULAR INTERVENTIONS, 2005, 5 (05) : 282 - 291
  • [6] We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders
    Cheng, Jianjun
    Kozikowski, Alan P.
    CHEMMEDCHEM, 2015, 10 (12) : 1963 - 1967
  • [7] Selective agents for serotonin2C(5-HT2C) receptor
    Lacivita, Enza
    Leopoldo, Marcello
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2006, 6 (18) : 1927 - 1970
  • [8] 5-Hydroxytryptamine 2C (5-HT2C) receptor agonists as potential antiobesity agents
    Nilsson, Bjorn M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2006, 49 (14) : 4023 - 4034
  • [9] New 5-HT2c receptor agonists
    Bishop, MJ
    Nilsson, BM
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (11) : 1691 - 1705
  • [10] Interactions of selective serotonin reuptake inhibitors with the serotonin 5-HT2C receptor
    Palvimaki, EP
    Roth, BL
    Majasuo, H
    Laakso, A
    Kuoppamaki, M
    Syvalahti, E
    Hietala, J
    PSYCHOPHARMACOLOGY, 1996, 126 (03) : 234 - 240